![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Simpson, Eric L.; Blauvelt, Andrew; Silverberg, Jonathan I.; Cork, Michael J.; Katoh, Norito; Mark, Thomas; Schneider, Shannon K. R. und Wollenberg, Andreas 
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
Warren, Richard B.; Strober, Bruce ORCID: https://orcid.org/0000-0002-8394-2057; Silverberg, Jonathan I. ORCID: https://orcid.org/0000-0003-3686-7805; Guttman, Emma ORCID: https://orcid.org/0000-0002-9363-324X; Andres, Philippe; Felding, Jakob; Tutkunkardas, Deniz ORCID: https://orcid.org/0000-0002-9390-6105; Kjøller, Kim; Sommer, Morten O. A. und French, Lars E. ORCID: https://orcid.org/0000-0002-4629-1486
(2023):
Oral orismilast: Efficacy and safety in moderate‐to‐severe psoriasis and development of modified release tablets.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 37, Nr. 4: S. 711-720
[PDF, 236kB]
ORCID: https://orcid.org/0000-0002-8394-2057; Silverberg, Jonathan I. ORCID: https://orcid.org/0000-0003-3686-7805; Guttman, Emma ORCID: https://orcid.org/0000-0002-9363-324X; Andres, Philippe; Felding, Jakob; Tutkunkardas, Deniz ORCID: https://orcid.org/0000-0002-9390-6105; Kjøller, Kim; Sommer, Morten O. A. und French, Lars E. ORCID: https://orcid.org/0000-0002-4629-1486
(2023):
Oral orismilast: Efficacy and safety in moderate‐to‐severe psoriasis and development of modified release tablets.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 37, Nr. 4: S. 711-720
[PDF, 236kB]
Simpson, Eric L.; Wollenberg, Andreas; Soong, Weily; Steffensen, Louise Abildgaard; Kurbasic, Azra; Schneider, Shannon; Zoidis, John und Silverberg, Jonathan I.
(2022):
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3).
In: Annals of Allergy Asthma & Immunology, Bd. 129, Nr. 5: S. 592-604
Simpson, Eric L.; Merola, Joseph F.; Silverberg, Jonathan I.; Reich, Kristian; Warren, Richard B.; Staumont-Salle, Delphine; Girolomoni, Giampiero; Papp, Kim; Bruin-Weller, Marjolein de; Thyssen, Jacob P.; Zachariae, Rebecca; Olsen, Christiana K. und Wollenberg, Andreas
(2022):
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
In: British Journal of Dermatology, Bd. 187, Nr. 6: S. 888-899
Wollenberg, Andreas; Marcoux, Danielle; Silverberg, Jonathan I.; Aoki, Valeria; Baselga, Eulalia; Zhang, Haixin; Levit, Noah A.; Taieb, Alain und Rossi, Ana B.
(2022):
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.
In: Acta Dermato-Venereologica, Bd. 102, adv00726
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Agner, Tove; Bissonnette, Robert; Cohen, David E.; Simpson, Eric; Wollenberg, Andreas und Thyssen, Jacob P.
(2021):
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.
In: Dermatitis, Bd. 32, Nr. 5: S. 319-326
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Gooderham, Melinda; Worm, Margitta; Rippon, Stephanie; O'Quinn, Sean; Merwe, Rene van der; Kragh, Nana; Kurbasic, Azra und Wollenberg, Andreas
(2021):
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study.
In: Annals of Allergy Asthma & Immunology, Bd. 126, Nr. 5: S. 576-583
Silverberg, Jonathan I.; Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Kabashima, Kenji; DeLozier, Amy M.; Sun, Luna; Cardillo, Tracy; Nunes, Fabio P. und Reich, Kristian
(2021):
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders An Extension Study of 2 Randomized Clinical Trials.
In: Jama Dermatology, Bd. 157, Nr. 6: S. 691-699
Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Silverberg, Jonathan I.; Papacharalambous, Jocelyne; Zhu, Linda; Zhang, Weidong; Beebe, Jean S.; Vincent, Michael; Peeva, Elena; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Chen, Linda; Sikirica, Vanja und Xenakis, Jason
(2021):
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.
In: Dermatitis, Bd. 32, Nr. 1S:
S53-S61
Alexis, Andrew F.; Rendon, Marta; Silverberg, Jonathan I.; Pariser, David M.; Lockshin, Benjamin; Griffiths, Christopher E. M.; Weisman, Jamie; Wollenberg, Andreas; Chen, Zhen; Davis, John D.; Li, Meng; Eckert, Laurent; Gadkari, Abhijit; Shumel, Brad; Rossi, Ana B.; Graham, Neil M. H. und Ardeleanu, Marius
(2019):
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials.
In: Journal of Drugs in Dermatology, Bd. 18, Nr. 8: S. 804-813
Wollenberg, Andreas; Howell, Michael D.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Kell, Christopher; Ranade, Koustubh; Moate, Rachel und van der Merwe, Rene
(2019):
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.
In: Journal of Allergy and Clinical Immunology, Bd. 143, Nr. 1: S. 135-141
Simpson, Eric L.; Bruin-Weller, Marjolein; Flohr, Carsten; Ardern-Jones, Michael R.; Barbarot, Sebastien; Deleuran, Mette; Bieber, Thomas; Vestergaard, Christian; Brown, Sara J.; Cork, Michael J.; Drucker, Aaron M.; Eichenfield, Lawrence F.; Fölster-Holst, Regina; Guttman-Yassky, Emma; Nosbaum, Audrey; Reynolds, Nick J.; Silverberg, Jonathan I.; Schmitt, Jochen; Seyger, Marieke M. B.; Spuls, Phyllis I.; Stalder, Jean-Francois; Su, John C.; Takaoka, Roberto; Traidl-Hoffmann, Claudia; Thyssen, Jacob P.; Schaft, Jorien van der; Wollenberg, Andreas; Irvine, Alan D. und Paller, Amy S.
(2017):
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
In: Journal of the American Academy of Dermatology, Bd. 77, Nr. 4: S. 623-633
Wollenberg, Andreas; Howell, Michael D.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Birrell, Claire; Kell, Chris; Dawson, Michelle und Merwe, Rene van der
(2017):
A phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD).
In: Journal of the American Academy of Dermatology, Bd. 76, Nr. 6:
AB20-AB20